Transforming BABE Studies with Advanced Electronic Data Capture

Experience how Navitas Life Sciences is modernizing Bioavailability & Bioequivalence (BABE) studies with secure, validated, and fully audit-ready electronic data capture workflows.

Our BABE-focused EDC framework enables faster study starts, traceable data and real-time monitoring, designed for first-to-market success.

Watch Exclusive Demonstration
Gain a first-hand view of how patient data is securely captured, monitored and managed across the full clinical lifecycle, from volunteer check-in to database lock.

Navitas Life Sciences BABE Highlights

  • 1,000+ BABE studies delivered
  • 100+ regulatory approvals
  • 500+ validated bioanalytical methods
  • Dedicated CPUs & state-of-the-art bioanalytical labs
  • Expertise in complex generics, inhalation and euglycemic clamp studies

Backed by advanced clinical data management and digital innovation, we support pharma and biotechs with speed and compliance excellence.

Fill the form now to watch the full video and explore how we support your BABE development goals.

© 2025 Navitas Life Sciences | Privacy Policy